The prognostic significance of smoking cessation after acute coronary syndromes: an observational, multicentre study from the Melbourne interventional group registry
- PMID: 28988174
- PMCID: PMC5640050
- DOI: 10.1136/bmjopen-2017-016874
The prognostic significance of smoking cessation after acute coronary syndromes: an observational, multicentre study from the Melbourne interventional group registry
Abstract
Objective: We aim to ascertain the prognostic significance of persistent smoking and smoking cessation after an acute coronary syndrome (ACS) in the era of percutaneous coronary intervention (PCI) and optimal secondary prevention pharmacotherapy.
Methods: Consecutive patients from the Melbourne Interventional Group registry (2005-2013) who were alive at 30 days post-ACS presentation were included in our observational cohort study. Patients were divided into four categories based on their smoking status: non-smoker; ex-smoker (quit >1 month before ACS); recent quitter (smoker at presentation but quit by 30 days) and persistent smoker (smoker at presentation and at 30 days). The primary endpoint was survival ascertained through the Australian National Death Index linkage. A Cox-proportional hazards model was used to estimate the adjusted HR and 95% CI for survival.
Results: Of the 9375 patients included, 2728 (29.1%) never smoked, 3712 (39.6%) were ex-smokers, 1612 (17.2%) were recent quitters and 1323 (14.1%) were persistent smokers. Cox-proportional hazard modelling revealed, compared with those who had never smoked, that persistent smoking (HR 1.78, 95% CI 1.36 to 2.32, p<0.001) was an independent predictor of increased hazard (mean follow-up 3.9±2.2 years) while being a recent quitter (HR 1.27, 95% CI 0.96 to 1.68, p=0.10) or an ex-smoker (HR 1.03, 95% CI 0.87 to 1.22, p=0.72) were not.
Conclusions: In a contemporary cohort of patients with ACS, those who continued to smoke had an 80% risk of lower survival while those who quit had comparable survival to lifelong non-smokers. This underscores the importance of smoking cessation in secondary prevention despite the improvement in management of ACS with PCI and pharmacotherapy.
Keywords: acute coronary syndromes; long-term mortality; percutaneous coronary intervention; secondary prevention; smoking.
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Conflict of interest statement
Competing interests: None declared.
Figures



Similar articles
-
Prognostic significance of suboptimal secondary prevention pharmacotherapy after acute coronary syndromes.Intern Med J. 2021 Mar;51(3):366-374. doi: 10.1111/imj.14750. Intern Med J. 2021. PMID: 31943665
-
Impact of cigarette smoking on extent of coronary artery disease and prognosis of patients with non-ST-segment elevation acute coronary syndromes: an analysis from the ACUITY Trial (Acute Catheterization and Urgent Intervention Triage Strategy).JACC Cardiovasc Interv. 2014 Apr;7(4):372-9. doi: 10.1016/j.jcin.2013.11.017. Epub 2014 Mar 14. JACC Cardiovasc Interv. 2014. PMID: 24630881 Clinical Trial.
-
Acute coronary syndrome and stable coronary artery disease: are they so different? Long-term outcomes in a contemporary PCI cohort.Int J Cardiol. 2013 Aug 20;167(4):1343-6. doi: 10.1016/j.ijcard.2012.04.011. Epub 2012 Apr 23. Int J Cardiol. 2013. PMID: 22534045
-
Smoking cessation after acute coronary syndrome: A systematic review and meta-analysis.Int J Clin Pract. 2021 Dec;75(12):e14894. doi: 10.1111/ijcp.14894. Epub 2021 Sep 30. Int J Clin Pract. 2021. PMID: 34541754
-
[Secondary prevention for coronary heart disease].MMW Fortschr Med. 2023 Mar;165(5):38-41. doi: 10.1007/s15006-023-2355-8. MMW Fortschr Med. 2023. PMID: 36894855 Review. German. No abstract available.
Cited by
-
A Face-Aging App for Smoking Cessation in a Waiting Room Setting: Pilot Study in an HIV Outpatient Clinic.J Med Internet Res. 2018 Aug 15;20(8):e10976. doi: 10.2196/10976. J Med Internet Res. 2018. PMID: 30111525 Free PMC article.
-
Sex Difference in Control of Low-Density Lipoprotein Cholesterol in Older Patients after Acute Coronary Syndrome.Geriatrics (Basel). 2022 Jun 24;7(4):71. doi: 10.3390/geriatrics7040071. Geriatrics (Basel). 2022. PMID: 35893318 Free PMC article.
-
Change in Smoking Behavior and Outcome After Ischemic Stroke: Post-Hoc Analysis of the SPS3 Trial.Stroke. 2023 Apr;54(4):921-927. doi: 10.1161/STROKEAHA.121.038202. Epub 2023 Mar 6. Stroke. 2023. PMID: 36876480 Free PMC article. Clinical Trial.
-
Smoking cessation for secondary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD014936. doi: 10.1002/14651858.CD014936.pub2. Cochrane Database Syst Rev. 2022. PMID: 35938889 Free PMC article.
-
The Prognosis of Coronary Artery Disease in a Brazilian Community Hospital: Findings from the ERICO Study.Arq Bras Cardiol. 2021 Nov;117(5):978-985. doi: 10.36660/abc.20200399. Arq Bras Cardiol. 2021. PMID: 34644783 Free PMC article. English, Portuguese.
References
-
- Wilson K, Gibson N, Willan A, et al. . Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. Arch Intern Med 2000;160:939–44. - PubMed
-
- Smith SC, Benjamin EJ, Bonow RO, et al. . AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. J Am Coll Cardiol 2011;58:2432–46. 10.1016/j.jacc.2011.10.824 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous